Rybelsus
Every GLP-1 the FDA has approved, and the active ingredient inside each one.
What is Rybelsus?
Semaglutide as a daily tablet at 3, 7 and 14 mg, approved for type 2 diabetes.
It is also the drug behind the 33% levothyroxine AUC interaction warning. The oral route is the whole complication: it only absorbs under strict fasting conditions, which is why sellers offering “oral semaglutide” owe you a straight answer about what is actually in it.
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Rybelsus comes up on this site
On GLP Watchdog, Rybelsus comes up in 5 seller reviews and 3 tools.
Tools that use it
Seller reviews that mention it
Connected terms
Other terms under Drugs and brands
Where the evidence lives
- The full GLP-1 glossary (149 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers